2 active not recruiting. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Active not recruiting 2 |
Follow Anal Basaloid Carcinoma: new trials by email Literature Review of Anal Basaloid Carcinoma trials Research Report on Anal Basaloid Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| EA2176: Phase 3 Clinical Trial of Carboplatin and Paclitaxel +/- Nivolumab in Metastatic Anal Cancer Patients Carboplatin, Nivolumab, Paclitaxel - Anal Basaloid Carcinoma, Anal Canal Cloacogenic Carcinoma | Phase 3 | Active not recruiting | National Cancer Institute (NCI) | 205 | 2020-11-17 | 2026-10-26 |
| Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer Biopsy Procedure, Biospecimen Collection, Colonoscopy - Anal Basaloid Carcinoma, Anal Canal Cloacogenic Carcinoma | Phase 3 | Active not recruiting | National Cancer Institute (NCI) | 344 | 2018-07-05 | 2026-11-02 |
Anal Canal Carcinoma (2) · Anus Neoplasms (2)
Anus Diseases (2) · Colorectal Neoplasms (2) · Digestive System Diseases (2) · Digestive System Neoplasms (2) · Gastrointestinal Diseases (2) · Gastrointestinal Neoplasms (2) · Intestinal Diseases (2) · Intestinal Neoplasms (2) · Neoplasms (2) · Neoplasms by Site (2) · Rectal Diseases (2) · Rectal Neoplasms (2)
Nivolumab (2) · Biopsy (1) · Carboplatin (1) · Colonoscopy (1) · Magnetic Resonance Spectroscopy (1) · Observation (1) · Paclitaxel (1) · Phantoms, Imaging (1) · Proctoscopy (1) · Sigmoidoscopy (1) · Specimen Handling (1) · Taxes (1) · Watchful Waiting (1) · X-Rays (1)
National Cancer Institute (NCI) (2)
United States (2) · Canada (1)
Cathy Eng (1) · Lakshmi Rajdev (1)
U10CA180820 (2)